EGFR and non-small cell lung carcinoma: In vitro studies also showed that the fast growth of non-small cell lung cancer (NSCLC) and leukemia depends on the high activity of SOD1, which controls the oncogenic KRAS and EGFR pathways [47,48], as well as other cancer cells and xenograft tumors [49].